Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Adjuvant ovarian function suppression in premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2–negative early breast cancer: a multi-center retrospective study

Fig. 7

Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score>1.42 and chemotherapy-treated. (A) Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score>1.42 and receiving chemotherapy before PSM. (B) Disease-free survival difference between underwent OFS or non-OFS among premenopausal patients with CR-score>1.42 and receiving chemotherapy after 1:1 PSM. OFS, ovarian function suppression; CR-score, composite recurrence risk score; PSM, propensity score matching

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us